Sandbox Turky: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 17: | Line 17: | ||
❑ High-risk stress test finding, defined as ANY of following <ref name="pmid22326193">{{cite journal| author=Marso SP, Teirstein PS, Kereiakes DJ, Moses J, Lasala J, Grantham JA| title=Percutaneous coronary intervention use in the United States: defining measures of appropriateness. | journal=JACC Cardiovasc Interv | year= 2012 | volume= 5 | issue= 2 | pages= 229-35 | pmid=22326193 | doi=10.1016/j.jcin.2011.12.004 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22326193 }} </ref>, OR | ❑ High-risk stress test finding, defined as ANY of following <ref name="pmid22326193">{{cite journal| author=Marso SP, Teirstein PS, Kereiakes DJ, Moses J, Lasala J, Grantham JA| title=Percutaneous coronary intervention use in the United States: defining measures of appropriateness. | journal=JACC Cardiovasc Interv | year= 2012 | volume= 5 | issue= 2 | pages= 229-35 | pmid=22326193 | doi=10.1016/j.jcin.2011.12.004 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22326193 }} </ref>, OR | ||
❑ Resting LVEF < 35% | :❑ Resting LVEF < 35% | ||
❑ High-risk treadmill score (≤ 11) | :❑ High-risk treadmill score (≤ 11) | ||
❑ Severe exercise LVEF < 35% | :❑ Severe exercise LVEF < 35% | ||
❑ Stress-induced large perfusion defect | :❑ Stress-induced large perfusion defect | ||
❑ Stress-induced multiple perfusion defects | :❑ Stress-induced multiple perfusion defects | ||
❑ Large, fixed perfusion defect with LV dilation OR increased lung uptake | :❑ Large, fixed perfusion defect with LV dilation OR increased lung uptake | ||
❑ LV dilation or increased lung uptake | :❑ LV dilation or increased lung uptake | ||
❑ Stress-induced moderate perfusion defect with LV dilation or increased lung uptake | :❑ Stress-induced moderate perfusion defect with LV dilation or increased lung uptake | ||
❑ Uncertain diagnosis following non-invasive test and need to confirm diagnosis, OR | ❑ Uncertain diagnosis following non-invasive test and need to confirm diagnosis, OR |
Revision as of 15:22, 17 April 2015
Is cardiac catheterization an emergency? | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refer to management of acute coronary syndromes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Confirm patient has ANY of the following indications for cardiac catheterization
❑ Canadian cardiovascular society (CCS) class III (i.e. symptoms with everyday living activities) or class IV angina (i.e. inability to perform any activity without angina or angina at rest) despite medical therapy, OR ❑ Angina plus systolic dysfunction, OR ❑ High-risk stress test finding, defined as ANY of following [1], OR
❑ Uncertain diagnosis following non-invasive test and need to confirm diagnosis, OR ❑ Systolic dysfunction with unexplained cause, OR ❑ Survivor of sudden cardiac death, polymorphic VT, or sustained monomorphic VT, OR ❑ Suspected spas m or non-atherosclerotic cause of ischemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ D01 }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ E01 }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ F01 }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ G01 }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ I01 }}} | {{{ I02 }}} | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ J01-}}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ K01 }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ L01 }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ M01 }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ N01 }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ O01 }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
- ↑ Marso SP, Teirstein PS, Kereiakes DJ, Moses J, Lasala J, Grantham JA (2012). "Percutaneous coronary intervention use in the United States: defining measures of appropriateness". JACC Cardiovasc Interv. 5 (2): 229–35. doi:10.1016/j.jcin.2011.12.004. PMID 22326193.